The Canadian Gene Cure Foundation
Enabling Canadians to lead the world in the discovery and advancement of cures for inherited diseases
The Canadian Gene Cure Foundation (CGCF) supports excellence in the research of human inherited diseases.
Our four key programs are designed to build a sustainable, cooperative research community in Canada.
- The Canadian Gene Cure Foundation (CGCF) works to advance cures for inherited diseases by investing in the best and brightest researchers in Canada. CGCF has a history of funding genetic research through is research grant program. In 2010, CGCF introduced a new research grant opportunity for post-doctoral researchers – the Champions of Genetics Programme. This programme was designed with multiple benefits, in that it celebrates high-caliber scientific excellence of both highly respected senior scientists, and the rising scientific stars that they have mentored.
- We provide high school students with an amazing hands-on opportunity to discover the world of genetic research in some of the top labs in the country GRFAW.
- We encourage and enable university students to pursue both an MD and a PhD degree in the field of genetics through our Scriver MD/PhD Studentships. Physicians who understand research and researchers who manage patients play a valuable role in the pursuit of cures and treatments for disease.
Together… We Can Discover Cures for Genetic Diseases
In November 2013, the Canadian College of Medical Geneticists voted unanimously for the Canadian Gene Cure Foundation to be the Charity of Choice for the association. The College is made up of individuals who have a doctoral degree and training in medical genetics.
“This is a very natural fit for both organizations,” said Sandra MacPherson, Board Chair of the Canadian Gene Cure Foundation. “We are honoured to have the support of the CCMG for the work we do providing research grants, scholarships and educational opportunities to medical genetics researchers. The programmes we coordinate all ultimately aim to bring improvements in patient care by enabling Canadian scientists to continue to pursue world-class research in medical genetics.”